American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer (Record no. 29395)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01928pab a2200361 454500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 150901b2007 xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | Tata Memorial Hospital |
| 041 ## - LANGUAGE CODE | |
| Language code of text/sound track or separate title | English |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | |
| Item number | |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Harris L |
| 245 ## - TITLE STATEMENT | |
| Title | American society of clinical oncology 2007 update of recommendations for the use of tumor markers in breast cancer |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Date of publication, distribution, etc. | 2007 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 5287-5312 |
| 490 ## - SERIES STATEMENT | |
| Series statement | |
| Volume/sequential designation | Vol 25 Issues 33 |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | Purpose: To update the recommendations for the use of tumor marker tests in the prevention, screening, treatment, and surveillance of breast cancer. Methods: For the 2007 update, an Update Committee composed of members from the full Panel was formed to complete the review and analysis of data published since 1999. Computerized literature searches of MEDLINE and the Cochrane Collaboration Library were performed. The Update Committee's literature review focused attention on available systematic reviews and metaanalyses of published tumor marker studies. In general, significant health outcomes (overall survival, disease-free survival, quality of life, lesser toxicity, and cost-effectiveness) were used for making recommendations. Recommendations and Conclusions: Thirteen categories of breast tumor markers were considered, six of which were new for the guideline. The following categories showed evidence of clinical utility and were recommended for use in practice: CA 15-3, CA 27.29, carcinoembryonic antigen, |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Recommendatios, |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Breast cancers |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Tumor markers |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Bast RC |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hayes DF |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Somerfield MR |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Taube S |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ravdin P |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Norton L |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mennel R |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fritsche H |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | |
| 773 ## - HOST ITEM ENTRY | |
| Host Biblionumber | 78078 |
| Main entry heading | Journal of Clinical Oncology |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) | |
| a | Nov |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
| a | USA |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) | |
| a | ASCO Special Article |
| Withdrawn status | Lost status | Damaged status | Not for loan | Permanent Location | Current Location | Date acquired | Cost, normal purchase price | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tata Memorial Hospital | Tata Memorial Hospital | 2008-01-09 | 0.00 | AR3138 | 2015-09-02 | 2015-09-02 | Articles |